BELLUS Health (BLU) Insider Trading & Ownership → [PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit Strategy (From DeFi Distribution) (Ad) Free BLU Stock Alerts Add Compare Share Share Insider TradesStock AnalysisInsider TradesStock AnalysisInsider Trades BELLUS Health (TSE:BLU) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.26%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)3Amount OfInsider Selling(Last 3 Years)C$1.00 M Get BLU Insider Trade Alerts Want to know when executives and insiders are buying or selling BELLUS Health stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BLU Insider Buying and Selling by Quarter Ad Smallcaps DailyIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closelyLearn how this American company is leading the lithium-ion revolution BELLUS Health Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/30/2022Pierre LarochelleDirectorSell35,667C$12.59C$448,976.2011/18/2022Joseph RusDirectorSell35,643C$12.14C$432,559.883/22/2022Francois DesjardinsSenior OfficerSell14,053C$8.47C$118,989.56 (Data available from 1/1/2013 forward) BLU Insider Trading Activity - Frequently Asked Questions Who is on BELLUS Health's Insider Roster? The list of insiders at BELLUS Health includes Francois Desjardins, Joseph Rus, and Pierre Larochelle. Learn more on insiders at BLU. What percentage of BELLUS Health stock is owned by insiders? 10.26% of BELLUS Health stock is owned by insiders. Learn more on BLU's insider holdings. Which BELLUS Health insiders have been selling company stock? The following insiders have sold BLU shares in the last 24 months: Joseph Rus (C$432,559.88), and Pierre Larochelle (C$448,976.20). How much insider selling is happening at BELLUS Health? Insiders have sold a total of 71,310 BELLUS Health shares in the last 24 months for a total of C$881,536.08 sold. More Insider Trading Tools from MarketBeat Related Companies: Fennec Pharmaceuticals Insider Selling Medicenna Therapeutics Insider Selling Oncolytics Biotech Insider Selling Theratechnologies Insider Selling ProMIS Neurosciences Insider Selling Small Pharma Insider Selling Microbix Biosystems Insider Selling Aptose Biosciences Insider Selling Antibe Therapeutics Insider Selling Resverlogix Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Top 4 Stocks With Notable Insider Buying3 Small Cap Tech Stocks That Insiders Are Buying3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying This page (TSE:BLU) was last updated on 6/10/2024 by MarketBeat.com Staff From Our Partners[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BELLUS Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BELLUS Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.